Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
Holding TMDX?
Track your performance easily
TMDX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$57.90 - $177.37
Previous CloseN/A
Volume1.17M
Average Volume (3M)2.35M
Market Cap
$1.95B
Enterprise Value$5.79B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)62.2
Beta1.84
Next Earnings
Mar 04, 2025EPS Estimate
0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.93
Shares Outstanding33,561,516
10 Day Avg. Volume3,787,012
30 Day Avg. Volume2,354,050
Standard Deviation0.26
R-Squared0.18
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.85
Price to Cash Flow (P/CF)71.00
P/FCF Ratio0.00
Enterprise Value/Market Cap2.97
Enterprise Value/Revenue14.44
Enterprise Value/Gross Profit37.58
Enterprise Value/Ebitda94.67
Forecast
1Y Price Target
$102.38Price Target Upside78.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
TransMedics Group News
Bulls Say, Bears Say
Bulls Say
Growth PotentialLonger term, TransMedics has significant potential to transform the US transplant market as the Organ Care System meaningfully improves on the limitations of cold storage within the $7B+ transplant system.
Market ExpansionThe company’s recent analyst day made it clear that the remaining opportunity for TransMedics is significant between the potential revitalization of heart and lung, future launches like next-gen OCS and kidney, and upside from an almost entirely untapped international market.
Technological AdvancementsTransMedics has the only portable multi-organ warm perfusion platform that has been approved by the FDA.
Bears Say
Financial GuidanceThe initial 2025 revenue guidance was below consensus expectations, indicating a potential challenge in meeting prior forecasts.
Management And StrategyA last minute CFO change came with a 2024 sales guide trim.
Market PerformanceHeart transplants declined 9.9% quarter over quarter, suggesting that Transmedics Group might not meet performance estimates.
---
Ownership Overview
3.32% Insiders
38.45% Mutual Funds
0.22% Other Institutional Investors
32.89% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TMDX FAQ
What was TransMedics Group Inc’s price range in the past 12 months?
TransMedics Group Inc lowest stock price was $57.90 and its highest was $177.37 in the past 12 months.
What is TransMedics Group Inc’s market cap?
TransMedics Group Inc’s market cap is $1.95B.
When is TransMedics Group Inc’s upcoming earnings report date?
TransMedics Group Inc’s upcoming earnings report date is Mar 04, 2025 which is in 42 days.
How were TransMedics Group Inc’s earnings last quarter?
TransMedics Group Inc released its earnings results on Oct 28, 2024. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.293 by -$0.173.
Is TransMedics Group Inc overvalued?
According to Wall Street analysts TransMedics Group Inc’s price is currently Undervalued.
Does TransMedics Group Inc pay dividends?
TransMedics Group Inc does not currently pay dividends.
What is TransMedics Group Inc’s EPS estimate?
TransMedics Group Inc’s EPS estimate is 0.16.
How many shares outstanding does TransMedics Group Inc have?
TransMedics Group Inc has 33,561,516 shares outstanding.
What happened to TransMedics Group Inc’s price movement after its last earnings report?
TransMedics Group Inc reported an EPS of $0.12 in its last earnings report, missing expectations of $0.293. Following the earnings report the stock price went down -29.895%.
Which hedge fund is a major shareholder of TransMedics Group Inc?
Among the largest hedge funds holding TransMedics Group Inc’s share is Driehaus Capital Management LLC. It holds TransMedics Group Inc’s shares valued at 226M.
---
TransMedics Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$102.38 (78.99% Upside)
$102.38 (78.99% Upside)
Blogger Sentiment
Bullish
TMDX Sentiment 90%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 7.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.6%
Last 30 Days ▲ 6.9%
Last 30 Days ▲ 6.9%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.28%
12-Months-Change
Fundamentals
Return on Equity
19.41%
Trailing 12-Months
Asset Growth
13.98%
Trailing 12-Months
Company Description
TransMedics Group Inc
TransMedics Group, Inc. is a commercial stage medical technology company, which engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in October 2018 and is headquartered in Andover, MA.
---
TMDX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with strong year-over-year growth in revenue and logistics services, alongside challenges in sequential revenue decline, gross margin pressure, and operational issues related to aircraft maintenance. The commitment to future growth through next-gen technologies is promising, but short-term challenges remain.Read More>---
TMDX Stock 12 Month Forecast
Average Price Target
$102.38
▲(78.99% Upside)
Technical Analysis
Inspire Medical Systems
―
InMode
―
Neuronetics
―
Nevro Corp
―
Staar Surgical
―
Irhythm Technologies
―
Best Analysts Covering TMDX
1 Year
1 Year Success Rate
12/21 ratings generated profit
1 Year Average Return
+44.97%
reiterated a buy rating 8 days ago
Copying William Plovanic's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +44.97% per trade.
---